Growth Potential With a small team of 11-50 employees and recent revenue estimates under 1 million dollars, Onkaido Therapeutics presents an opportunity for tailored sales solutions that can support their scaling efforts and enhance operational efficiency.

Innovation Focus As a biotechnology research firm based in Madrid, Onkaido is likely engaged in cutting-edge research, indicating a need for advanced laboratory equipment, research tools, and collaboration software to accelerate their R&D activities.

Funding & Investment While current funding details are unavailable, the company's presence among similar biotech firms suggests potential for investment in innovative technologies or partnerships that can bolster their research capabilities and market competitiveness.

Regional Presence Located in the Madrid biotech hub, Onkaido can benefit from regional networks and collaborations, offering opportunities for local suppliers of biotech materials, lab services, and regional funding programs aimed at biotech growth.

Market Positioning With comparable firms like Aeglea BioTherapeutics and Cytovia Therapeutics, Onkaido has room to differentiate through unique research focus areas, advanced technology adoption, or strategic partnerships that can drive faster growth and market recognition.